Alzheimer's disease is one of the world’s most prevalent brain disorders, being extremely difficult to treat. Alzheimer's ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...

Alzheimer’s disease is notorious for robbing individuals of memory and cognitive function. Researchers have struggled for ...

Using a novel quantitative chemoproteomic strategy, the team uncovered a protective role of dopamine (DA) in regulating the function of the microtubule-associated protein Tau. This discovery ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

“Interestingly, KIBRA restored synaptic function and memory in mice, despite not fixing the problem of toxic tau protein accumulation,” said Kristeen Pareja-Navarro, co-first author of the study. “Our ...

Glutamate, a key neurotransmitter involved in brain function, plays a crucial role in processes such as mood regulation and memory formation. However, research has also linked glutamate to the toxic ...

Worley was part of a team that showed how the loss of one of the two proteins used in the test disrupts synapses and leads to ...

Those findings were integrated with data collected from the participants on cerebrospinal fluid and brain-scan biomarkers of amyloid- β and tau protein, cognitive function, age, sex and Alzheimer ...

As previously announced, results from the Phase 1b study showed dose-dependent reductions in soluble tau protein in cerebrospinal ... measures of cognition and function. The Phase 2 CELIA study ...

people’s brain function is already declining. The scans are also expensive and not available at all hospitals. More sensitive ways to detect amyloid and tau, another protein related to the ...